A
Adam M. Kaye
Researcher at University of the Pacific (United States)
Publications - 123
Citations - 3300
Adam M. Kaye is an academic researcher from University of the Pacific (United States). The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 17, co-authored 77 publications receiving 2371 citations. Previous affiliations of Adam M. Kaye include Beth Israel Deaconess Medical Center & Louisiana State University.
Papers
More filters
Journal ArticleDOI
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects
Amber N. Edinoff,Catherine A. Nix,Amira S. Odisho,Caroline P Babin,Alyssa G Derouen,Salim C Lutfallah,Elyse M. Cornett,Kevin S. Murnane,Adam M. Kaye,Alan D. Kaye +9 more
TL;DR: The use of DBZs has been a subject of multiple recent clinical studies, likely due to increasing presence and availability on the internet drug market and lack of regulation as mentioned in this paper . But, the most common effects noted by recreational users include heavy hypnosis and sedation, long-lasting amnesia, and rapid development of tolerance.
Journal ArticleDOI
Nutraceuticals: potential roles and potential risks for pain management.
TL;DR: The basic mechanisms of coagulation and the role of commonly used herbs known to possess side effects, which can cause excessive bleeding are reviewed and a number of potential useful herbal derived agents for pain management are reviewed.
Journal ArticleDOI
Feasibility and Safety of Prone Position Transport for Severe Hypoxemic Respiratory Failure Due to Coronavirus Disease 2019.
Raghu Seethala,Michael A. Frakes,Michael N. Cocchi,Jason Cohen,James Dargin,Frank Friedman,Christian Grant,Adam M. Kaye,Susan R. Wilcox +8 more
TL;DR: Critical care transport of severe hypoxemic respiratory failure patients with coronavirus disease 2019 in the prone position is safe when performed by a dedicated team of critical care nurse and paramedics with an established protocol.
Journal ArticleDOI
Cenobamate, a Sodium Channel Inhibitor and Positive Allosteric Modulator of GABAA Ion Channels, for Partial Onset Seizures in Adults: A Comprehensive Review and Clinical Implications.
Dustin R. Latimer,Amber N. Edinoff,Rachel D. Ruff,Kelsey C. Rooney,Kayla M. Penny,Shaan B. Patel,Suresh Sabbenahalli,Adam M. Kaye,Elyse M. Cornett,Omar Viswanath,Ivan Urits,Alan D. Kaye +11 more
TL;DR: Cenobamate, a newly FDA approved drug used to treat partial-onset seizures in adult patients, has demonstrated promise in that it works on two proposed mechanisms that are commonly associated with epilepsy as mentioned in this paper.
Journal ArticleDOI
Anticoagulants: Newer Ones, Mechanisms, and Perioperative Updates
TL;DR: With a growing number of new anticoagulant/antiplatelet agents being developed, it is likely that an increasing number of patients taking these drugs will present for surgery and other procedures, and it is crucial for anesthesiologists to remain current on recommendations regarding discontinuation or need to continue the newer antICOagulants/ antiplatelet drugs.